Vanguard Group’s Beneficient BENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.67M Buy
237,129
+235,582
+15,228% +$1.29M ﹤0.01% 3618
2025
Q3
$11.8K Hold
1,547
﹤0.01% 4337
2025
Q2
$3.71K Hold
1,547
﹤0.01% 4270
2025
Q1
$3.87K Hold
1,547
﹤0.01% 4275
2024
Q4
$9.22K Hold
1,547
﹤0.01% 4283
2024
Q3
$15.2K Sell
1,547
-2,702
-64% -$53.1K ﹤0.01% 4313
2024
Q2
$75.5K Buy
4,249
+2,702
+175% +$88K ﹤0.01% 4254
2024
Q1
$66.3K Hold
1,547
﹤0.01% 4283
2023
Q4
$481K Buy
1,547
+693
+81% +$327K ﹤0.01% 4037
2023
Q3
$1.42M Buy
+854
New +$1.34M ﹤0.01% 3711

Other funds holding BENF

Vanguard Group's BENF Position: Q4 2025 in Review

Vanguard Group increased its Beneficient (BENF) stake by 15,228% in Q4 2025, buying an estimated $1.29M and bringing the position to 237,129 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3618.

Vanguard Group first reported a position in BENF in Q3 2023 and has held it in 10 quarters since. 13 funds tracked by Wall St. Rank hold BENF as of Q4 2025.

  • Vanguard Group held 237,129 shares of Beneficient worth $1.67M as of Q4 2025.
  • Vanguard Group bought 235,582 Beneficient shares in Q4 2025, an estimated $1.29M.
  • Beneficient made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3618 holding.
  • Vanguard Group first reported a position in Beneficient in Q3 2023 and has held it in 10 quarters since.
  • 13 funds tracked by Wall St. Rank held Beneficient as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.